Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RUVBL2 pseudogene 1 (RUVBL2P1), also called RuvB like AAA ATPase 2 pseudogene, is a non-functional pseudogene related to the RUVBL2 gene. As a pseudogene, RUVBL2P1 does not encode an active protein and lacks demonstrated biological activity or molecular function. It is present in the genome as an inactive copy and does not serve as a therapeutic target, receptor, enzyme, or other functional biomolecule. All relevant biological, clinical, and therapeutic features pertain to the functional RUVBL2 gene, not its pseudogene. Clarification: If you are seeking information on the functional RUVBL2 gene (not the pseudogene RUVBL2P1), this gene encodes an AAA+ ATPase involved in transcriptional regulation, chromatin remodeling, DNA repair, and cancer biology[1][2][3]. The pseudogene RUVBL2P1, however, has no such known roles. If you intended to refer to the functional RUVBL2 protein, please clarify your query. Summary: RUVBL2P1 is a genomic pseudogene with no known functional, therapeutic, or biological relevance. All cited information about molecular function or disease role in current literature concerns the parent functional gene, RUVBL2, not RUVBL2P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RUVBL2 pseudogene 1 (RUVBL2P1).